Overview
Khaled Tolba is a Hematologist Oncology specialist and an Oncologist in Seattle, Washington. Dr. Tolba is rated as an Experienced provider by MediFind in the treatment of Polymorphous Low Grade Adenocarcinoma. His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Lung Adenocarcinoma, and Pleuropulmonary Blastoma.
His clinical research consists of co-authoring 21 peer reviewed articles and participating in 8 clinical trials. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
7 Clinical Trials
The Association Of University Physicians
Cristina Rodriguez is a Hematologist Oncology specialist and a Hematologist in Seattle, Washington. Dr. Rodriguez is rated as a Distinguished provider by MediFind in the treatment of Polymorphous Low Grade Adenocarcinoma. Her top areas of expertise are Salivary Gland Tumors, Head and Neck Squamous Cell Carcinoma (HNSCC), Laryngeal Cancer, and Thyroid Cancer. Dr. Rodriguez is currently accepting new patients.
Northwest Medical Specialties PLLC
Andrea Veatch is a Hematologist Oncology specialist and an Oncologist in Tacoma, Washington. Dr. Veatch is rated as a Distinguished provider by MediFind in the treatment of Polymorphous Low Grade Adenocarcinoma. Her top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Dehydration, and Testicular Yolk Sac Tumor. Dr. Veatch is currently accepting new patients.
Rafael Santana is an Oncologist in Seattle, Washington. Dr. Santana is rated as a Distinguished provider by MediFind in the treatment of Polymorphous Low Grade Adenocarcinoma. His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), and Pleuropulmonary Blastoma.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Lung CancerDr. Tolba isDistinguished. Learn about Lung Cancer.
- Advanced
- Lung AdenocarcinomaDr. Tolba isAdvanced. Learn about Lung Adenocarcinoma.
- Non-Small Cell Lung Cancer (NSCLC)
- Pleuropulmonary BlastomaDr. Tolba isAdvanced. Learn about Pleuropulmonary Blastoma.
- Experienced
- Acinic Cell Carcinoma of Salivary Glands
- Adenoid Cystic CarcinomaDr. Tolba isExperienced. Learn about Adenoid Cystic Carcinoma.
- ALK-Positive Non-Small Cell Lung Cancer
- EGFR Positive Lung CancerDr. Tolba isExperienced. Learn about EGFR Positive Lung Cancer.
- Large-Cell Lung CarcinomaDr. Tolba isExperienced. Learn about Large-Cell Lung Carcinoma.
- Laryngeal CancerDr. Tolba isExperienced. Learn about Laryngeal Cancer.